Vascular endothelial growth factor and fibroblast growth factor 2 delivery from spinal cord bridges to enhance angiogenesis following injury

Journal of Biomedical Materials Research - Part A

Volumn 98 A, Issue 3, 2011, Pages 372-382

  De Laporte, Laura ^a   Des Rieux, Anne ^b   Tuinstra, Hannah M ^a   Zelivyanskaya, Marina L ^a   De Clerck, Nora M ^c   Postnov, Andrei A ^c   Préat, Véronique ^b   Shea, Lonnie D ^a  

^a Northwestern University   (United States)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

angiogenesis; PLG; protein delivery; spinal cord bridges; spinal cord injury

Indexed keywords

ANGIOGENESIS; PLG; PROTEIN DELIVERY; SPINAL CORD INJURY; SPINAL CORDS;

BLOOD VESSELS; CELL CULTURE; CELL DEATH; ENDOTHELIAL CELLS; FIBROBLASTS; LEACHING; MICROSPHERES; PATIENT REHABILITATION; PEPTIDES;

DOSIMETRY;

FIBROBLAST GROWTH FACTOR 2; MICROSPHERE; POLYGLACTIN; RECOMBINANT FIBROBLAST GROWTH FACTOR; RECOMBINANT VASCULOTROPIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG MEGADOSE; DRUG RELEASE; ENDOTHELIUM CELL; FEMALE; IN VIVO STUDY; NERVE GROWTH; NERVE REGENERATION; NEUROFILAMENT; NONHUMAN; PROTEIN LOCALIZATION; RAT; SPINAL CORD INJURY;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; CELL LINE; DRUG IMPLANTS; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; MICROSPHERES; NEOVASCULARIZATION, PHYSIOLOGIC; POLYGLACTIN 910; RATS; RATS, LONG-EVANS; SPINAL CORD; SPINAL CORD INJURIES; SPINAL CORD REGENERATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79960358602     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.33112     Document Type: Article

References (54)

1. Storkebaum E, Lambrechts D, Carmeliet P,. VEGF: Once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays 2004; 26: 943-954. (Pubitemid 39273068)
2. Jimenez Hamann MC, Tator CH, Shoichet MS,. Injectable intrathecal delivery system for localized administration of EGF and FGF-2 to the injured rat spinal cord. Exp. Neurol 2005; 194: 106-119. (Pubitemid 40719747)
3. Jones LL, Oudega M, Bunge MB, Tuszynski MH,. Neurotrophic factors, cellular bridges and gene therapy for spinal cord injury. J Physiol 2001; 533 (Pt 1): 83-89. (Pubitemid 32499360)
4. Nakahara Y, Gage FH, Tuszynski MH,. Grafts of fibroblasts genetically modified to secrete NGF, BDNF, NT-3, or basic FGF elicit differential responses in the adult spinal cord. Cell Transpl 1996; 5: 191-204. (Pubitemid 26096180)
5. De Laporte L, Yan AL, Shea LD,. Local gene delivery from ECM-coated poly(lactide-co-glycolide) multiple channel bridges after spinal cord injury. Biomaterials 2009; 30: 2361-2368.
6. De Laporte L, Yang Y, Zelivyanskaya ML, Cummings BJ, Anderson AJ, Shea LD,. Plasmid releasing multiple channel bridges for transgene expression after spinal cord injury. Mol Ther 2009; 17: 318-326.
7. Stokols S, Tuszynski MH,. Freeze-dried agarose scaffolds with uniaxial channels stimulate and guide linear axonal growth following spinal cord injury. Biomaterials 2006; 27: 443-451. (Pubitemid 41457247)
8. De Laporte L, Huang A, Ducommun MM, Zelivyanska ML, Aviles MO, Adler AF, Shea LD,. Patterned transgene expression in multiple-channel bridges after spinal cord injury. Acta Biomater 6: 2889-2897.
9. Biondi M, Ungaro F, Quaglia F, Netti PA,. Controlled drug delivery in tissue engineering. Adv Drug Deliv Rev 2008; 60: 229-242. (Pubitemid 350236401)
10. Tessmar JK, Gopferich AM,. Matrices and scaffolds for protein delivery in tissue engineering. Adv Drug Deliv Rev 2007; 59: 274-291. (Pubitemid 46879975)
11. Willerth SM, Sakiyama-Elbert SE Approaches to neural tissue engineering using scaffolds for drug delivery. Adv Drug Deliv Rev 2007; 59: 325-338. (Pubitemid 46879972)
12. Widenfalk J, Lipson A, Jubran M, Hofstetter C, Ebendal T, Cao Y, Olson L,. Vascular endothelial growth factor improves functional outcome and decreases secondary degeneration in experimental spinal cord contusion injury. Neuroscience 2003; 120: 951-960. (Pubitemid 36966647)
13. Facchiano F, Fernandez E, Mancarella S, Maira G, Miscusi M, D'Arcangelo D, Cimino-Reale G, Falchetti ML, Capogrossi MC, Pallini R,. Promotion of regeneration of corticospinal tract axons in rats with recombinant vascular endothelial growth factor alone and combined with adenovirus coding for this factor. J Neurosurg 2002; 97: 161-168. (Pubitemid 34693714)
14. Ruiz de Almodovar C, Lambrechts D, Mazzone M, Carmeliet P,. Role and therapeutic potential of VEGF in the nervous system. Physiol Rev 2009; 89: 607-648.
15. Sakakibara Y, Nishimura K, Tambara K, Yamamoto M, Lu F, Tabata Y, Komeda M,. Prevascularization with gelatin microspheres containing basic fibroblast growth factor enhances the benefits of cardiomyocyte transplantation. J Thorac Cardiovasc Surg 2002; 124: 50-56.
16. Yau TM, Fung K, Weisel RD, Fujii T, Mickle DA, Li RK,. Enhanced myocardial angiogenesis by gene transfer with transplanted cells. Circulation 2001; 104 (12, Suppl 1): I218-I222. (Pubitemid 32884806)
17. Kim HM, Hwang DH, Lee JE, Kim SU, Kim BG,. Ex vivo VEGF delivery by neural stem cells enhances proliferation of glial progenitors, angiogenesis, and tissue sparing after spinal cord injury. PLoS ONE 2009; 4: e4987.
18. Carmeliet P, Tessier-Lavigne M,. Common mechanisms of nerve and blood vessel wiring. Nature 2005; 436: 193-200. (Pubitemid 41021263)
19. Eichmann A, Le Noble F, Autiero M, Carmeliet P,. Guidance of vascular and neural network formation. Curr Opin Neurobiol 2005; 15: 108-115. (Pubitemid 40249969)
20. Autiero M, De Smet F, Claes F, Carmeliet P,. Role of neural guidance signals in blood vessel navigation. Cardiovasc Res 2005; 65: 629-638. (Pubitemid 40138983)
21. Sondell M, Lundborg G, Kanje M,. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J Neurosci 1999; 19: 5731-5740. (Pubitemid 29327910)
22. Mukouyama YS, Shin D, Britsch S, Taniguchi M, Anderson DJ,. Sensory nerves determine the pattern of arterial differentiation and blood vessel branching in the skin. Cell 2002; 109: 693-705. (Pubitemid 34722266)
23. Shen Q, Goderie SK, Jin L, Karanth N, Sun Y, Abramova N, Vincent P, Pumiglia K, Temple S,. Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 2004; 304: 1338-1340. (Pubitemid 38697433)
24. Krum JM, Mani N, Rosenstein JM,. Angiogenic and astroglial responses to vascular endothelial growth factor administration in adult rat brain. Neuroscience 2002; 110: 589-604. (Pubitemid 34270531)
25. Sondell M, Lundborg G, Kanje M,. Vascular endothelial growth factor stimulates Schwann cell invasion and neovascularization of acellular nerve grafts. Brain Res 1999; 846: 219-228. (Pubitemid 29505158)
26. Hobson MI, Green CJ, Terenghi G,. VEGF enhances intraneural angiogenesis and improves nerve regeneration after axotomy. J Anat 2000; 197 (Pt 4): 591-605. (Pubitemid 32051540)
27. Yang Y, De Laporte L, Zelivyanskaya M, Whittlesey KJ, Anderson A, Cummings BJ, Shea LD,. Multiple channel bridges for spinal cord injury: Cellular characterization of host response. Tissue Eng Part A 2009; 15: 3283-3295.
28. De Clerck N, Postnov A,. High Resolution X-Ray Microtomography: Applications in Biomedical Research. London: Wiley; 2007. p 57-77.
29. Ennett AB, Kaigler D, Mooney DJ,. Temporally regulated delivery of VEGF in vitro and in vivo. J Biomed Mater Res A 2006; 79: 176-184. (Pubitemid 44452868)
30. Yang Y, De Laporte L, Rives CB, Jang JH, Lin WC, Shull KR, Shea LD,. Neurotrophin releasing single and multiple lumen nerve conduits. J Control Release 2005; 104: 433-446. (Pubitemid 40724940)
31. Jang JH, Rives CB, Shea LD,. Plasmid delivery in vivo from porous tissue-engineering scaffolds: Transgene expression and cellular transfection. Mol Ther 2005; 12: 475-483. (Pubitemid 41150133)
32. Peters MC, Polverini PJ, Mooney DJ,. Engineering vascular networks in porous polymer matrices. J Biomed Mater Res 2002; 60: 668-678. (Pubitemid 34492606)
33. Cleland JL, Duenas ET, Park A, Daugherty A, Kahn J, Kowalski J, Cuthbertson A,. Development of poly-(D,L -lactide-co-glycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis. J Control Release 2001; 72: 13-24. (Pubitemid 32522340)
34. Chen RR, Silva EA, Yuen WW, Mooney DJ,. Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation. Pharm Res 2007; 24: 258-264. (Pubitemid 46072185)
35. Kaigler D, Wang Z, Horger K, Mooney DJ, Krebsbach PH,. VEGF scaffolds enhance angiogenesis and bone regeneration in irradiated osseous defects. J Bone Miner Res 2006; 21: 735-744.
36. Sun Q, Chen RR, Shen Y, Mooney DJ, Rajagopalan S, Grossman PM,. Sustained vascular endothelial growth factor delivery enhances angiogenesis and perfusion in ischemic hind limb. Pharm Res 2005; 22: 1110-1116. (Pubitemid 41127068)
37. Golub JS, Kim YT, Duvall CL, Bellamkonda RV, Gupta D, Lin AS, Weiss D, Robert Taylor W, Guldberg RE,. Sustained VEGF delivery via PLGA nanoparticles promotes vascular growth. Am J Physiol Heart Circ Physiol 2010; 298: H1959-H1965.
38. Przybylski M,. A review of the current research on the role of bFGF and VEGF in angiogenesis. J Wound Care 2009; 18: 516-519.
39. Pepper MS, Ferrara N, Orci L, Montesano R,. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 1992; 189: 824-831. (Pubitemid 23032448)
40. Asahara T, Bauters C, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM,. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 1995; 92 (9 Suppl): II365-II371.
41. Ferrara N, Alitalo K,. Clinical applications of angiogenic growth factors and their inhibitors. Nat Med 1999; 5: 1359-1364.
42. Sheridan MH, Shea LD, Peters MC, Mooney DJ,. Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. J Control Release 2000; 64: 91-102. (Pubitemid 30035310)
43. Rives CB, des Rieux A, Zelivyanskaya M, Stock SR, Lowe WL Jr, Shea LD,. Layered PLG scaffolds for in vivo plasmid delivery. Biomaterials 2009; 30: 394-401.
44. Murphy WL, Peters MC, Kohn DH, Mooney DJ,. Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials 2000; 21: 2521-2527.
45. Riddle KW, Kong HJ, Leach JK, Fischbach C, Cheung C, Anseth KS, Mooney DJ,. Modifying the proliferative state of target cells to control DNA expression and identifying cell types transfected in vivo. Mol Ther 2007; 15: 361-368. (Pubitemid 46111887)
46. Bartholdi D, Rubin BP, Schwab ME,. VEGF mRNA induction correlates with changes in the vascular architecture upon spinal cord damage in the rat. Eur J Neurosci 1997; 9: 2549-2560. (Pubitemid 28082944)
47. George ML, Eccles SA, Tutton MG, Abulafi AM, Swift RI,. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: Clinical evidence of platelet scavenging? Clin Cancer Res 2000; 6: 3147-3152. (Pubitemid 30637740)
48. Pantely GA, Porter JM,. Therapeutic angiogenesis: Time for the next phase. J Am Coll Cardiol 2000; 36: 1245-1247.
49. Brauker JH, Carr-Brendel VE, Martinson LA, Crudele J, Johnston WD, Johnson RC,. Neovascularization of synthetic membranes directed by membrane microarchitecture. J Biomed Mater Res 1995; 29: 1517-1524.
50. Lim TC, Chian KS, Leong KF,. Cryogenic prototyping of chitosan scaffolds with controlled micro and macro architecture and their effect on in vivo neo-vascularization and cellular infiltration. J Biomed Mater Res A 2010; 94: 1303-1311.
51. Ozawa CR, Banfi A, Glazer NL, Thurston G, Springer ML, Kraft PE, McDonald DM, Blau HM,. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J Clin Invest 2004; 113: 516-527. (Pubitemid 38542501)
52. von Degenfeld G, Banfi A, Springer ML, Wagner RA, Jacobi J, Ozawa CR, Merchant MJ, Cooke JP, Blau HM,. Microenvironmental VEGF distribution is critical for stable and functional vessel growth in ischemia. FASEB J 2006; 20: 2657-2659.
53. Richardson TP, Peters MC, Ennett AB, Mooney DJ,. Polymeric system for dual growth factor delivery. Nat Biotechnol 2001; 19: 1029-1034. (Pubitemid 33041886)
54. Van Den Bosch L, Storkebaum E, Vleminckx V, Moons L, Vanopdenbosch L, Scheveneels W, Carmeliet P, Robberecht W,. Effects of vascular endothelial growth factor (VEGF) on motor neuron degeneration. Neurobiol Dis. 2004; 17: 21-28. (Pubitemid 39209309)